I went long on this I think Thurs or Friday. Higher highs and higher lows, nice basing pattern with breakout above triangle. My stop is @ $11.14 (about 10% plus is below swing low). Below $12.03, I would view as negative if it drops back into it's consolidation zone.
XOM looking nice today too.
I normally avoid ETFs as a general rule, but this ETF fit the pattern.
Put in a new 7 day high here after consolidating, I will follow price higher. Price bouncing off the 20 EMA. Stop = $12.12 (seems to respect the 50 EMA) BB squeezing together.
0.2% risk on capital
From yahoo finance -
Evoqua Water Technologies is a leading provider of mission-critical water and wastewater treatment solutions, offering a broad portfolio of...
Higher lows, but not higher highs yet. I have an alert set for $5.11 and if it breaks, I will buy. Double bottom pattern in place with nice consolidation. Earnings positive. Actually I may pick up some shares here, but would be pure speculation and outside of strategy.
From Yahoo Finance- Feb. 20th
SRC Energy (SRCI) came out with quarterly earnings of $0.30 per...
Buy signal here today, low volatility reading. Uptrend with higher low in place. Stop loss less than 10%, swing low @ $16.70. We can see that the long term downtrend has been broken now.
0.2% capital at risk
Making new highs and higher lows. Nice consolidation along base. Earnings winner. Moving averages splitting open. MACD up. Double bottom. Volatility factor slightly rising, and quietly trending after earnings. Positive fundamentals. I like so many things about this one!
Using 10% stop loss from entry for future to better track my results, which is near swing low...
Closed the gap and breaking out of a consolidation area - headed to new highs?? Looking for a metal that is not too far into a trend...
Moving averages on $GG are heading upwards in a nice trend. My stop will be the 20 EMA which is below the current supply area. 1st target = $13.04.
Compared to $NEM, ATR is less volatile on this one.
Watching for a break above $14.75. nice base consolidation here. Former runner. Ascending wedge pattern. 10, 20 and 50 EMA forming a nice floor for a stop loss. See if it holds $14 or not. No position yet.
Risk: biotechs normally I avoid, but this has a nice pattern. Also on guard for any overall market weakness which will probably negate this as a potential...
Hmmm...looks like going down and fill that gap, buyers will be trapped and jump ship. Short and medium term downtrend here and losing the 200 EMA. 5 days of lower lows on the daily is a bad sign combined with low volume, I hope it continues to bleed.
FB is passé to the youth of today....the glass is half empty here.
tight stop = $164.49 Target = $153.30...
Uptrend. Moving Average crossover. Positive earnings. Using the 20 EMA as a stop.
Risk: resistance @ the 100 and 200
Keeping a close eye on the SPY for ANY SORT of weakness here esp. with the 200 overhead -a particular hot spot.
Super small share size until the 200 is resolved. Break above and hold = add more shares.
Actively long 0.2% capital
If this can break through resistance @ $11.35 and resolve the gap @ $12.04, then I would be a buyer. Has support from the 10 and 20 ema, but will it hold? No position here. Any positive news might give it the juice it needs.
Class action lawsuit
David Zalik is the cofounder and CEO of financial technology company GreenSky.
Just entering the Ichimoku cloud. Higher highs, higher lows. Nice consolidation and low volatility over last 4 weeks, ideal would be 6 weeks. Also has a short-term moving average crossover which is positive as well as a 1.67% slope to the 20 ema over last few trading days. I have a 0.2% capital risk entry @ 9.56 with a stop loss of $8.82. Will trail with a 10 ema...
Earnings winner on Keytruda sales. In @ $77.00. Tight stop - half the way down on today's candlestick ~ $76.49. (I am not about to lose money on this one-much). Has support at $76.50 ish. Nice long strong uptrend, hopefully the momentum will last. Will close after a 2-3 day swing. Will trail stop @ the 3 ema if it continues up - surfing the wave. Target could be...
Watching for entry on any signs of bullishness here above $37.48. Starting to find support on the cloud. Q4 announcement Feb 1st. New drug(s) release - migraine med + propofol injectable. 0.2 % capital. Super tight stop - a few cents below 20 ema. Consider waiting for price to tighten up a bit more before getting in.
Earnings winner. Dividend payer. Probability that this will go higher is positive based on previous chart data. Stock is trading in the lower 1/4 of entire hx of price action going back to year 2016.
Also double bottom formation of late. Gap up is bullish. Exponential moving average crossovers = bullish.
R/R = 1.7.
Loose stop = 29.64
Target = $38
Clear uptrend with moving average squeeze. Breakout from base = BUY SIGNAL! Previous runner. 2x volume in last 2-3 days. RSI = 72. Weekly and monthly solidly UP. I bought up here you could wait for it to come back in I guess. Focusing on trend here, rather than entry, and letting runners run. Risking 0.2 % capital since most uptrends fail. 1st resistance = $22.20...